Evidence map›Paper›PMID 27398086›Full record

ArticleImmunity & ageing : I & A2016

Redox modulation of cellular stress response and lipoxin A4 expression by Hericium Erinaceus in rat brain: relevance to Alzheimer's disease pathogenesis.

A Trovato, R Siracusa, R Di Paola, M Scuto, M L Ontario, Ornella Bua, Paola Di Mauro, M A Toscano, C C T Petralia, L Maiolino and 3 more

Open access · goldAbstract read
In one paragraph

Article in Immunity & ageing : I & A, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Redox Modulation of Meniere Disease byCurrent neuropharmacology · 2024
    Article
  15. Review
  16. Neurotrophic and Neuroprotective Effects ofInternational journal of molecular sciences · 2023
    Review
  17. Modulation of TLR4/NFκB Pathways in Autoimmune Myocarditis.Antioxidants (Basel, Switzerland) · 2023
    Article
  18. MemophenolInternational journal of molecular sciences · 2023
    Article
  19. Lipoxin alleviates oxidative stress: a state-of-the-art review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  20. Natural Compounds Such asBiomedicines · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

A Trovato *Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
R Siracusa *Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
R Di PaolaDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
M ScutoDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
M L OntarioDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
Ornella BuaDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
Paola Di MauroDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
M A ToscanoDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
C C T PetraliaDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
L MaiolinoDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
A SerraDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
S CuzzocreaDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
Vittorio CalabreseDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy.
University of Catania · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere has been a recent upsurge of interest in complementary medicine, especially dietary supplements and foods functional in delaying the onset of age-associated neurodegenerative diseases. Mushrooms have long been used in traditional medicine for thousands of years, being now increasingly recognized as antitumor, antioxidant, antiviral, antibacterial and hepatoprotective agent also capable to stimulate host immune responses.

resultsHere we provide evidence of neuroprotective action of Hericium Herinaceus when administered orally to rat. Expression of Lipoxin A4 (LXA4) was measured in different brain regions after oral administration of a biomass Hericium preparation, given for 3 month. LXA4 up-regulation was associated with an increased content of redox sensitive proteins involved in cellular stress response, such as Hsp72, Heme oxygenase -1 and Thioredoxin. In the brain of rats receiving Hericium, maximum induction of LXA4 was observed in cortex, and hippocampus followed by substantia Nigra, striatum and cerebellum. Increasing evidence supports the notion that oxidative stress-driven neuroinflammation is a fundamental cause in neurodegenerative diseases. As prominent intracellular redox system involved in neuroprotection, the vitagene system is emerging as a neurohormetic potential target for novel cytoprotective interventions. Vitagenes encode for cytoprotective heat shock proteins 70, heme oxygenase-1, thioredoxin and Lipoxin A4. Emerging interest is now focussing on molecules capable of activating the vitagene system as novel therapeutic target to minimize deleterious consequences associated with free radical-induced cell damage, such as in neurodegeneration. LXA4 is an emerging endogenous eicosanoid able to promote resolution of inflammation, acting as an endogenous "braking signal" in the inflammatory process. In addition, Hsp system is emerging as key pathway for modulation to prevent neuronal dysfunction, caused by protein misfolding.

conclusionsConceivably, activation of LXA4 signaling and modulation of stress responsive vitagene proteins could serve as a potential therapeutic target for AD-related inflammation and neurodegenerative damage.

Indexed as

Alzheimer’s diseaseHeat shock protein70Heme Oxygenase-1Lipoxin A4Nutritional mushrooms

Identifiers

PMID27398086
PMCPMC4938991
OpenAlexW2469199334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.